TY - JOUR TI - The impact of the "American Society Of Breast Surgeons' 2019 consensus guidelines on genetic testing for hereditary breast cancer" on cancer genetic counselors DO - https://doi.org/doi:10.7282/t3-4ba4-nm68 PY - 2020 AB - In February 2019, the American Society of Breast Surgeons (ASBrS) released a guideline recommending genetic testing be made available to all women with a breast cancer diagnosis. This guideline was based on findings in several papers outlining the number of individuals harboring mutations in a breast and ovarian cancer susceptibility gene who would not otherwise be found given the current National Comprehensive Cancer Network (NCCN) guidelines for cancer genetic testing (National Comprehensive Cancer Network, V1 2020). To determine the impact of this guideline on practicing cancer genetic counselors (GC), we created a survey asking GCs about their initial observations of the impact of the guideline on referral patterns from breast surgeons. Results showed 59% of respondents noted a change in referral patterns with breast surgeons referring more patients after the release of the ASBrS guideline. Thirty-seven percent of GCs reported that breast surgeons are referring all patients with breast cancer. GCs did not significantly change which breast cancer patients to whom they offered genetic testing. Our study found over 50% of cancer GCs agree that all women with a personal history of breast cancer should be offered genetic testing. This data supports increased coverage of genetic testing for these individuals as well as exemplifies the increased demand for GCs in the cancer genetics setting. KW - American Society of Breast Surgeons KW - Microbiology and Molecular Genetics LA - English ER -